CVS Health and Centene Report Q3 Financial News
CVS Health, hit by a literal financial meltdown, reported relatively good recovery news for Q3 2025. Its troubled Aetna insurance business and pharmacy benefit management Caremark are recovering. Because of this, CVS Health is forecasting double-digit earnings growth in 2026.
CVS Health had $103 billion in revenue for Q3. Revenue was up 7.8% year over year. The company recorded a Q3 net loss of $3.99 billion, compared with net income of $71 million, or 7 cents per share, in the same period for 2024. The decline was due to a $5.7 billion goodwill impairment charge from the healthcare delivery unit. Aetna had $36 billion in revenue in the third quarter, up 9% year over year. The medical cost ratio dropped from 95.2% to 92.8%.
Centene raised its yearly profit guidance despite ongoing struggles with health insurance Exchange spending and huge cuts to the federal health programs that are the foundation of its business. Centene posted a $6.6 billion loss in Q3 after incurring a one-time impairment charge related to ongoing market headwinds. The goodwill impairment charge was $6.7 billion and tied in part to the changes in the One Big Beautiful Bill Act. But Centene is making good progress on its turnaround. The company’s medical loss ratio was 92.7% in the third quarter, up from 89.2% at the same time last year but down sequentially.
Revenues were $49.7 billion in the quarter, which also beat Wall Street forecasts. By comparison, Centene reported $42 billion in revenue and $713 million in profit in the prior year quarter. Through the first nine months of 2026, the company posted $145.1 billion in revenue and $5.6 billion in losses. It brought in $122.3 billion in revenue and $3 billion in profit through the first three quarters of 2024.
Centene also emphasized its commitment to the Exchange line of business, saying even a smaller population after a subsidy expiration will still make coverage more affordable for many.
In other news, UnitedHealth Group is projecting its Medicare Advantage (MA) enrollment will decrease by 1 million people in 2026. That is up from a 600,000-member decrease it projected in July.
Additional articles: https://www.fiercehealthcare.com/payers/centene-posts-66b-loss-writedown-cost-pressures-continue and https://www.modernhealthcare.com/insurance/mh-centene-marketplace-congress-medicare-medicaid/ and https://www.healthcaredive.com/news/centene-value-writedown-q3-2025-medicaid-centene/804074/ and https://www.beckerspayer.com/financial/centene-ceo-prescription-drug-plans-steering-medicare-revenue/ and https://www.beckerspayer.com/financial/cvs-health-reports-4b-q3-loss-but-raises-earnings-outlook/ and https://www.beckerspayer.com/financial/centene-posts-6-6b-loss-but-steep-revenue-increase-for-q3/ and https://www.modernhealthcare.com/insurance/mh-cvs-health-earnings-oak-street-health/ and https://www.beckerspayer.com/payer/medicare-advantage/unitedhealth-projects-1-million-member-drop-in-medicare-advantage-enrollment/
(Some articles may require a subscription.)
#healthplans #centene #cvshealth #margins
